Claims
- 1. A process for the production of oligonnucleotides which comprises:
- (a) converting an inorganic silica into a coupling agent-silica,
- (b) combining the coupling agent-silica with a blocked nucleoside to obtain a blocked nucleoside-modified support; and
- (c) removing the blocking group from the blocked nucleoside-modified support to provide for the coupling of nucleotides to the nucleoside-modified support.
- 2. A process for the production of oligonucleotides which comprise:
- (a) treating an inorganic silica with a coupling agent which agent has a reactive group capable of reacting with a reactive group carried on a nucleoside; and
- (b) combining the treated silica with a nucleoside or a blocked nucleoside to obtain a nucleoside-modified support or a blocked nucleoside-modified support.
- 3. A process for the production of oligonucleotides which comprises:
- (a) providing an inorganic silica;
- (b) converting the silica into an amino-silica;
- (c) providing a nucleoside
- (d) combining the amino-silica and the nucleoside to obtain a nucleoside-modified support; and
- (e) attaching nucleotides to the nucleoside-modified support.
- 4. A process for the support of oligonucleotides which comprises:
- (a) converting a silica gel into a coupling agent-silica gel;
- (b) combining the coupling agent-silica gel with a blocked nucleoside to obtain a blocked nucleoside-modified support; and
- (c) removing the blocking group from the blocked nucleoside-modified support to provide for the coupling of nucleotides to the nucleoside-modified support.
- 5. A process for the production of oligonucleotides which comprise:
- (a) treating a silica gel with a coupling agent which agent has a reactive group capable of reacting with a reactive group carried on a nucleoside; and
- (b) combining the treated silica gel with a nucleoside or a blocked nucleoside to obtain a nucleoside-modified support or a blocked nucleoside-modified support.
- 6. A process for the production of oligonucleotides which comprises:
- (a) providing a silica gel;
- (b) converting the silica gel into an amino-silica gel;
- (c) providing a nucleoside
- (d) combining the amino-silica gel and the nucleoside to obtain a nucleoside-modified support; and
- (e) attaching nucleotides to the nucleoside-modified support.
- 7. A process for the production of oligonucleotides which comprises:
- (a) providing a silica gel support material;
- (b) converting said silica gel to a derivatize silica gel containing aminoalkyl or hydroxyalkyl groups;
- (c) providing a nucleoside modified to contain the half ester of a dicarboxylic acid; and
- (d) combining the nucleoside ester with the derivatized silica gel to obtain a nucleoside modified silica gel support.
- 8. A process according to claim 7 in which the derivatized silica gel contains aminoalkyl groups.
- 9. A process according to claim 8 in which the dicarboxylic acid is succinic acid.
- 10. A process according to claim 8 in which the succinic anhydride is use in step (c).
- 11. A process for the production of oligonucleotides which
- (a) providing a silica gel support material;
- (b) converting the silica gel to a derivatized silica
- (c) reacting the derivatized silica gel with a
- (d) condensing the free carboxy groups on silica with a freehydroxy group of a nucleoside to obtain a nucleoside modified silica gel support.
- 12. A process according to claim 11 in which the derivatized silica contains aminoalkyl groups.
- 13. A process according to claim 11 in which the dicarboxylic acid is succinic acid.
- 14. A process for production of oligonucleotides which comprises the step of condensing the 3'-OH or 5'-OH group of a nucleoside or oligonucleotide covalently linked to an inorganic polymer by a coupling agent through the 5'-O- or 3'-O-, respectively, of said nucleoside or oligonucleotide with a phosphite compound of the formula: ##STR5## wherein R is a blocking group; B is a nucleosides or deoxynucleoside base; A is H or OR; R.sub.1 is lower alkyl; and X is formed by the removal of the hydrogen atom from a ring nitrogen of a nitrogen herterocyclic compound which contains unsaturated bonds in the ring structure.
- 15. The process according to claim 14 wherein the phosphite compound is of the formula: ##STR6## wherein substituents R, R.sub.1, X, A and B are previously defined and said condensation occurs through the 5'-OH of said nucleoside or oligonucleotide.
- 16. The process according to claim 14 in which the heterocyclic compound is triazole.
- 17. The process according to claim 14 in which the heterocyclic compound is tetrazole.
Parent Case Info
This is a continuation of application Ser. No. 601,813 filed Jun. 18, 1984, now U.S. Pat. No. 4,458,066.
Government Interests
The inventions described herein were made in the course of work under a grant or award from the Department of Health, Education and Welfare.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
4458066 |
Caruthers et al. |
Jul 1984 |
|